This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Early Breast Cancer
In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response?
Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.
In Breast Cancer, Circulating MicroRNA May Predict Long-Term Survival
These results suggest that circulating microRNA expression profiles may be potential biomarkers that can help gauge the prognosis for early-stage breast cancer.
Disseminated Tumor Cells in High-Risk, Early Stage Breast Cancer
This study suggests that DTC positivity post-NAC represents a high-risk disease state, as illustrated by larger tumors at pretreatment, and offers further clinical evidence that DTCs are part of an intermediate step involved in metastasis pathogenesis.
Chemotherapy in Breast Cancer: We Need to Discuss Menopausal Symptoms
A thematic analysis of transcripts of clinical visits of patients with breast cancer undergoing chemotherapy treatment highlighted an unmet need to improve communication about the menopausal symptoms that may occur with treatment.
Patients with Breast Cancer Benefit from COVID-19 Boosters
Patients with breast cancer appear to have a diminished immunogenicity to the first-generation SARS-CoV2 vaccines. Immune responses improve with booster doses and should be considered for these vulnerable populations to ensure immunity against all COVID-19 variants.
Breast Cancer in Young Women: How Does it Affect Fertility?
According to a new study, breast cancer was associated with increased risks of infertility, premature ovarian insufficiency, and early menopause — even in patients who didn’t receive chemotherapy.
In Patients with Breast Cancer, How Did COVID-19 Affect Access to Care?
A new study assessed changes in self-reported healthcare utilization before and during the COVID-19 pandemic to determine its effect on patients with early-stage hormone receptor-positive breast cancer newly prescribed with adjuvant endocrine therapy.